Regenerative Medicine News

Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit

PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired – January 21, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D.,...

read more

Stem Cells from the Edge of Space

Stem cells have been lauded for their potential to cure a large array of cell based conditions, from muscular dystrophy to cancer to Parkinson’s Disease. But they have another, lesser known use: as tools for research into how human cells respond to an almost limitless...

read more

When is a cure, a cure?

What happens when a cell-based therapy gets characterized as a "cure"? A Patient’s Answer May Be Surprising. How is using the word “cure” at this stage of our clinical translation of regenerative medicine likely to impact patients the most? I’ve considered these...

read more